retatrutide triumph As a medical school professor, I have watched obesity pharmacology jump three generations in five years. Eli Lilly just announced TRIUMPH-1 results unlike anything short of bariatric surgery. (1/4) Retatrutide Achieves Up to 30.3%

Scacioc et al., 2017)

She didnt think quitting the drugs would be that big of a deal: She had lost as much as she wanted to, and in her mind, the companys messaging throughout her two years had suggested that, unless you were a diabetic, there was no need to stay on the GLP-1. But Isherwood told Fortune that within six to eight months, she gained back about 20 pounds as she reverted to old behaviors when stressors arose in her lifea familiar pattern that shed experienced before

Ferroptosis: A flexible constellation of related biochemical mechanisms

This table summarizes 1-year incidence of all-cause mortality and major adverse cardiovascular events (MACE) among RAGLP-1 RA versus RAnoGLP-1 RA cohorts, postpropensity score matching